Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Gabelli Funds to Host Pump, Valve & Water Systems Symposium at The Yale Club, New York, NY
-
Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
-
Capstreet-backed hh2 Strengthens its Leadership Team with New CRO and CTO Appointments
-
Applied UV Inc. Announces Receipt of Provisional Patent for Our Pulse Modulated UVC LED System to be Added to Our Patented Fighter Flex LED Solution Expanding Significant Revenue Opportunity
-
Human Resource Standards Institute℠ Introduces Workplace Wellness Organizational Certification
-
DMC Global Announces Strategic Alternatives Process for DynaEnergetics and NobelClad Businesses
-
Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya™ as Trade Name for TNX-102 SL for the Management of Fibromyalgia
-
Applied UV Inc. Announces Receipt of Provisional Patent for Our Pulse Modulated UVC LED System to be Added to Our Patented Fighter Flex LED Solution Expanding Significant Revenue Opportunity
-
Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference Call
-
Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
-
Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
-
Bitfarms to Ring Nasdaq Closing Bell on January 30th
-
GRIID to Begin Trading on Nasdaq Global Market Under Ticker “GRDI”
-
TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer
-
Orion Group Holdings, Inc. Rebrands TAS Concrete Construction to Orion
-
MERCURY SYSTEMS, INC. (NASDAQ: MRCY) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Mercury Syste
-
THE ESTÉE LAUDER COMPANIES INC. (NYSE: EL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against The
-
MOBILEYE GLOBAL INC. (NASDAQ: MBLY) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Mobileye Globa
-
ALLOVIR, INC. (NASDAQ: ALVR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against AlloVir, Inc.
-
CUMMINS INC. (NYSE: CMI) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Cummins Inc.
-
ASSERTIO HOLDINGS, INC. (NASDAQ: ASRT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Assertio Ho
-
BIONTECH SE (NASDAQ: BNTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioNTech SE
-
DADA NEXUS LIMITED (NASDAQ: DADA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Dada Nexus Limit
-
INSPIRE MEDICAL SYSTEMS, INC. (NYSE: INSP) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Inspire
-
DRIVEN BRANDS HOLDINGS INC. (NASDAQ: DRVN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Driven
-
ON SEMICONDUCTOR CORPORATION (NASDAQ: ON) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against ON Semic
-
MICROVAST HOLDINGS, INC. (NASDAQ: MVST) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Microvast
-
Akoustis Secures a wBMS Design Win with Tier-1 Automotive Product Supplier
-
EHANG HOLDINGS LIMITED (NASDAQ: EH) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against EHang Holdings
-
Gabelli Funds to Host Pump, Valve & Water Systems Symposium at The Yale Club, New York, NY
-
CW Petroleum Corp (CWPE) Reports Revenues for Q4-2023, Year-End
-
Marquette National Corporation Declares a Dividend of $0.28 per Share and Announces a New Common Stock Repurchase Program
-
OTC Markets Group Welcomes Cipher Pharmaceuticals Inc. to OTCQX
-
Schouw & Co. share buy-back programme, week 4 2024
-
Oxford Biomedica completes acquisition of ABL Europe
-
ARMGO Pharma Publishes Positive Phase 1b Trial Results of Rycal® ARM210 for the Treatment of Ryanodine Receptor 1 Related Myopathies
-
Form 8.3 - AXA INVESTMENT MANAGERS: LondonMetric Property plc
-
ANI Pharmaceuticals to Participate at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
-
DSM: Net Asset Value(s)
-
Amplify ETFs Completes Acquisition to Reach $9.1 Billion AUM Across 31 ETFs
-
Ring Energy Announces Production Results and Continued Debt Reduction for Fourth Quarter 2023 and Partial Guidance for the First Quarter 2024
-
Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to Market
-
Form 8.3 - LondonMetric Property plc
-
Oculis to Present at Upcoming February Investor Conferences
-
Comstock Inc. to Present at the Battery & Precious Metals Virtual Investor Conference on January 30, 2024
-
Comstock Inc. to Present at the Battery & Precious Metals Virtual Investor Conference on January 30, 2024
-
KFSH&RC-Madinah Receives Prestigious 2023 Press Ganey Human Experience Guardian of Excellence Award
-
KFSH&RC-Madinah Receives Prestigious 2023 Press Ganey Human Experience Guardian of Excellence Award
-
Panbela Announces Pricing of Approximately $9.0 Million Public Offering
-
Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
